Litigation Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
✉ Email this page to a colleague
Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-05-31 |
| Court | District Court, D. Delaware | Date Terminated | 2018-10-05 |
| Cause | no cause specified | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 9,399,012; 9,610,265 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Mallinckrodt IP v. B. Braun Medical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-08-03 | 16 | U.S. Patent No. 9,399,012 (“the ’012 patent”) and U.S. Patent No. 9,610,265 (“the ’265 patent”) (collectively… action for infringement of the patents-in-suit pursuant to the Patent Laws of the United States, 35 … THE PATENTS-IN-SUIT 21. The ’012 patent, titled “Reduced Dose Intravenous…sole assignee of the ’012 patent. A true and correct copy of the ’012 patent is attached as Exhibit A.…sole assignee of the ’265 patent. A true and correct copy of the ’265 patent is attached as Exhibit B. | External link to document | |
| 2017-06-01 | 6 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,399,012 B2; 9,610,265 B2; .…2017 5 October 2018 1:17-cv-00660 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
